Treatment of Euglycemic DKA in Pregnant Females

Immediate Management Priorities

The American Diabetes Association recommends starting continuous intravenous insulin infusion immediately, even if blood glucose is normal or only mildly elevated, in pregnant women with euglycemic DKA 1, 2, 3
The American College of Obstetricians and Gynecologists suggests simultaneously administering 10% dextrose intravenously to adequately meet the higher carbohydrate demands of the placenta and fetus in the third trimester 1, 2, 3
The Endocrine Society states that this dual approach is critical because pregnancy creates a ketogenic state where DKA occurs at lower glucose levels than in non-pregnant individuals, and the fetus requires continuous glucose supply 1, 2, 3
The American Association of Clinical Endocrinologists recommends that the insulin drip resolves ketosis while dextrose prevents hypoglycemia and meets fetal metabolic needs 1, 2

The Society for Maternal-Fetal Medicine advises beginning aggressive intravenous fluid replacement immediately as a cornerstone of DKA treatment in pregnancy, although the initial statement was incomplete due to ignored references, the concept is supported by the need to restore tissue perfusion and dilute ketone bodies 4

The American College of Obstetricians and Gynecologists recommends monitoring and replacing potassium aggressively, as insulin therapy drives potassium intracellularly and can precipitate life-threatening hypokalemia 4
The Endocrine Society suggests checking serum potassium before starting insulin if possible, and replacing as needed to maintain levels in safe range 4

The American Diabetes Association recommends measuring β-hydroxybutyrate levels (preferred over urine ketones) to monitor treatment response, as resolution of acidosis or reduction in blood β-hydroxybutyrate marks successful treatment 4
The Society for Maternal-Fetal Medicine advises monitoring arterial blood gases, serum glucose hourly, and electrolytes every 2-4 hours during acute management 4

The American College of Obstetricians and Gynecologists states that pregnancy creates accelerated starvation, insulin resistance, and respiratory alkalosis that promote ketosis at lower glucose levels, thus maintaining high clinical suspicion for DKA even when glucose is <200-250 mg/dL 5, 4
The Endocrine Society recommends looking for classic symptoms: nausea, vomiting, abdominal pain, Kussmaul respirations, altered mental status, and dehydration 4

The American Diabetes Association suggests that the placenta and fetus have continuous high carbohydrate demands that persist even during maternal ketoacidosis, necessitating dextrose administration alongside insulin 1, 2, 3
The American College of Obstetricians and Gynecologists recommends anticipating dramatic improvement in insulin sensitivity and rapid resolution of ketoacidosis after delivery of the fetus and placenta 1, 2

The American Association of Clinical Endocrinologists recommends educating patients with type 1 diabetes to check ketones regularly, especially during illness, poor oral intake, or hyperemesis 1, 2, 3
The Endocrine Society suggests prescribing ketone test strips and providing clear instructions on when to seek emergency care 1, 2, 3

The American College of Obstetricians and Gynecologists advises not waiting for hyperglycemia to diagnose DKA in pregnancy—euglycemic DKA is common and can be missed if relying solely on glucose levels 5, 4
The American Diabetes Association recommends not giving insulin without dextrose in pregnant women with DKA, as this fails to meet fetal metabolic needs and can perpetuate ketosis 1, 2, 3